 | • レポートコード：QAF27792 • 出版社/出版日：QYResearch / 2021年4月13日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のマイトマイシンC市場について種類別（2Mg、10Mg、40Mg、その他）、用途別（がん治療、眼科用、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・マイトマイシンC市場の概要 ・世界の主要地域別マイトマイシンC市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のマイトマイシンC市場規模2016-2021：種類別（2Mg、10Mg、40Mg、その他） ・世界のマイトマイシンC市場予測2012-2027：種類別（2Mg、10Mg、40Mg、その他） ・世界のマイトマイシンC市場規模2016-2021：用途別（がん治療、眼科用、その他） ・世界のマイトマイシンC市場予測2012-2027：用途別（がん治療、眼科用、その他） ・マイトマイシンCのアメリカ市場規模と予測2016-2021 ・マイトマイシンCのヨーロッパ市場規模と予測2016-2021 ・マイトマイシンCの中国市場規模と予測2016-2021 ・マイトマイシンCの日本市場規模と予測2016-2021 ・マイトマイシンCの東南アジア市場規模と予測2016-2021 ・マイトマイシンCのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Kyowa-kirin、Intas Pharmaceuticals、Teva、Bristol-Myers Squibb、Aspen、Contura、Alkem Laboratories、Varifarma、APOGEPHA） ・マイトマイシンCの製造コスト分析 ・販売チャネル、流通業者、顧客 ・マイトマイシンCの市場動向・機会・課題 ・調査の結論 |
Mitomycin C market, Mitomycin C is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.).
In the last several years, Global market of Mitomycin C was experienced an upward trend rapidly, with an average growth rate of 4.76%. In 2016, Global Revenue of Mitomycin C is nearly 119.83 M USD; the actual production is about 17370 K Unit.
The global average price of Mitomycin C is in the increasing trend, from 6.30 USD/Unit in 2012 to 6.90 USD/Unit in 2016. With the situation of global economy, prices will be in increasing trend in the following five years.
The classification of Mitomycin C includes 2 Mg, 10 Mg, 40 Mg, and others. The proportion of 2 Mg in 2016 is about 41.5%, and the proportion is in decreasing trend from 2012 to 2016.
Mitomycin C is widely used in Cancer Treatment, Ophthalmic Use, and other field. The most proportion of Mitomycin C is Cancer Treatment, and the proportion in 2016 is 69%. The trend of Cancer Treatment is decreasing.
Japan is the largest supplier of Mitomycin C, with a production market share nearly 26.5% in 2016. India is the second largest supplier of Mitomycin C Media, enjoying production market share nearly 25% in 2016.
North America is the largest consumption place, with a consumption market share nearly 36% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 32.6%.
Market competition is not intense. Kyowa-kirin, Intas Pharmaceuticals, Teva, Bristol-Myers Squibb, Aspen, Speciality European Pharma, etc. are the leaders of the industry.
Market Analysis and Insights: Global Mitomycin C Market
The global Mitomycin C market was valued at US$ 106.2 in 2020 and will reach US$ 93 million by the end of 2027, growing at a CAGR of -2.2% during 2022-2027.
Global Mitomycin C Scope and Market Size
The global Mitomycin C market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mitomycin C market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
2 Mg
10 Mg
40 Mg
Other
Segment by Application
Cancer Treatment
Ophthalmic Use
Others
The Mitomycin C market is analysed and market size information is provided by regions (countries). Segment by Application, the Mitomycin C market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Kyowa-kirin
Intas Pharmaceuticals
Teva
Bristol-Myers Squibb
Aspen
Contura
Alkem Laboratories
Varifarma
APOGEPHA
1 Mitomycin C Market Overview
1.1 Mitomycin C Product Scope
1.2 Mitomycin C Segment by Type
1.2.1 Global Mitomycin C Sales by Type (2016 & 2021 & 2027)
1.2.2 2 Mg
1.2.3 10 Mg
1.2.4 40 Mg
1.2.5 Other
1.3 Mitomycin C Segment by Application
1.3.1 Global Mitomycin C Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Cancer Treatment
1.3.3 Ophthalmic Use
1.3.4 Others
1.4 Mitomycin C Market Estimates and Forecasts (2016-2027)
1.4.1 Global Mitomycin C Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Mitomycin C Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Mitomycin C Price Trends (2016-2027)
2 Mitomycin C Estimates and Forecasts by Region
2.1 Global Mitomycin C Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Mitomycin C Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Mitomycin C Sales Market Share by Region (2016-2021)
2.2.2 Global Mitomycin C Revenue Market Share by Region (2016-2021)
2.3 Global Mitomycin C Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Mitomycin C Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Mitomycin C Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Mitomycin C Estimates and Projections (2016-2027)
2.4.2 Europe Mitomycin C Estimates and Projections (2016-2027)
2.4.3 China Mitomycin C Estimates and Projections (2016-2027)
2.4.4 Japan Mitomycin C Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Mitomycin C Estimates and Projections (2016-2027)
2.4.6 India Mitomycin C Estimates and Projections (2016-2027)
3 Global Mitomycin C Competition Landscape by Players
3.1 Global Top Mitomycin C Players by Sales (2016-2021)
3.2 Global Top Mitomycin C Players by Revenue (2016-2021)
3.3 Global Mitomycin C Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mitomycin C as of 2020)
3.4 Global Mitomycin C Average Price by Company (2016-2021)
3.5 Manufacturers Mitomycin C Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Mitomycin C Market Size by Type
4.1 Global Mitomycin C Historic Market Review by Type (2016-2021)
4.1.1 Global Mitomycin C Sales Market Share by Type (2016-2021)
4.1.2 Global Mitomycin C Revenue Market Share by Type (2016-2021)
4.1.3 Global Mitomycin C Price by Type (2016-2021)
4.2 Global Mitomycin C Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Mitomycin C Sales Forecast by Type (2022-2027)
4.2.2 Global Mitomycin C Revenue Forecast by Type (2022-2027)
4.2.3 Global Mitomycin C Price Forecast by Type (2022-2027)
5 Global Mitomycin C Market Size by Application
5.1 Global Mitomycin C Historic Market Review by Application (2016-2021)
5.1.1 Global Mitomycin C Sales Market Share by Application (2016-2021)
5.1.2 Global Mitomycin C Revenue Market Share by Application (2016-2021)
5.1.3 Global Mitomycin C Price by Application (2016-2021)
5.2 Global Mitomycin C Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Mitomycin C Sales Forecast by Application (2022-2027)
5.2.2 Global Mitomycin C Revenue Forecast by Application (2022-2027)
5.2.3 Global Mitomycin C Price Forecast by Application (2022-2027)
6 North America Mitomycin C Market Facts & Figures
6.1 North America Mitomycin C Sales by Company
6.1.1 North America Mitomycin C Sales by Company (2016-2021)
6.1.2 North America Mitomycin C Revenue by Company (2016-2021)
6.2 North America Mitomycin C Sales Breakdown by Type
6.2.1 North America Mitomycin C Sales Breakdown by Type (2016-2021)
6.2.2 North America Mitomycin C Sales Breakdown by Type (2022-2027)
6.3 North America Mitomycin C Sales Breakdown by Application
6.3.1 North America Mitomycin C Sales Breakdown by Application (2016-2021)
6.3.2 North America Mitomycin C Sales Breakdown by Application (2022-2027)
7 Europe Mitomycin C Market Facts & Figures
7.1 Europe Mitomycin C Sales by Company
7.1.1 Europe Mitomycin C Sales by Company (2016-2021)
7.1.2 Europe Mitomycin C Revenue by Company (2016-2021)
7.2 Europe Mitomycin C Sales Breakdown by Type
7.2.1 Europe Mitomycin C Sales Breakdown by Type (2016-2021)
7.2.2 Europe Mitomycin C Sales Breakdown by Type (2022-2027)
7.3 Europe Mitomycin C Sales Breakdown by Application
7.3.1 Europe 133 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 133 Sales Breakdown by Application (2022-2027)
8 China Mitomycin C Market Facts & Figures
8.1 China Mitomycin C Sales by Company
8.1.1 China Mitomycin C Sales by Company (2016-2021)
8.1.2 China Mitomycin C Revenue by Company (2016-2021)
8.2 China Mitomycin C Sales Breakdown by Type
8.2.1 China Mitomycin C Sales Breakdown by Type (2016-2021)
8.2.2 China Mitomycin C Sales Breakdown by Type (2022-2027)
8.3 China Mitomycin C Sales Breakdown by Application
8.3.1 China 241 Sales Breakdown by Application (2016-2021)
8.3.2 China 241 Sales Breakdown by Application (2022-2027)
9 Japan Mitomycin C Market Facts & Figures
9.1 Japan Mitomycin C Sales by Company
9.1.1 Japan Mitomycin C Sales by Company (2016-2021)
9.1.2 Japan Mitomycin C Revenue by Company (2016-2021)
9.2 Japan Mitomycin C Sales Breakdown by Type
9.2.1 Japan Mitomycin C Sales Breakdown by Type (2016-2021)
9.2.2 Japan Mitomycin C Sales Breakdown by Type (2022-2027)
9.3 Japan Mitomycin C Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Mitomycin C Market Facts & Figures
10.1 Southeast Asia Mitomycin C Sales by Company
10.1.1 Southeast Asia Mitomycin C Sales by Company (2016-2021)
10.1.2 Southeast Asia Mitomycin C Revenue by Company (2016-2021)
10.2 Southeast Asia Mitomycin C Sales Breakdown by Type
10.2.1 Southeast Asia Mitomycin C Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Mitomycin C Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Mitomycin C Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Mitomycin C Market Facts & Figures
11.1 India Mitomycin C Sales by Company
11.1.1 India Mitomycin C Sales by Company (2016-2021)
11.1.2 India Mitomycin C Revenue by Company (2016-2021)
11.2 India Mitomycin C Sales Breakdown by Type
11.2.1 India Mitomycin C Sales Breakdown by Type (2016-2021)
11.2.2 India Mitomycin C Sales Breakdown by Type (2022-2027)
11.3 India Mitomycin C Sales Breakdown by Application
11.3.1 India Mitomycin C Sales Breakdown by Application (2016-2021)
11.3.2 India Mitomycin C Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Mitomycin C Business
12.1 Kyowa-kirin
12.1.1 Kyowa-kirin Corporation Information
12.1.2 Kyowa-kirin Business Overview
12.1.3 Kyowa-kirin Mitomycin C Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Kyowa-kirin Mitomycin C Products Offered
12.1.5 Kyowa-kirin Recent Development
12.2 Intas Pharmaceuticals
12.2.1 Intas Pharmaceuticals Corporation Information
12.2.2 Intas Pharmaceuticals Business Overview
12.2.3 Intas Pharmaceuticals Mitomycin C Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Intas Pharmaceuticals Mitomycin C Products Offered
12.2.5 Intas Pharmaceuticals Recent Development
12.3 Teva
12.3.1 Teva Corporation Information
12.3.2 Teva Business Overview
12.3.3 Teva Mitomycin C Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Teva Mitomycin C Products Offered
12.3.5 Teva Recent Development
12.4 Bristol-Myers Squibb
12.4.1 Bristol-Myers Squibb Corporation Information
12.4.2 Bristol-Myers Squibb Business Overview
12.4.3 Bristol-Myers Squibb Mitomycin C Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bristol-Myers Squibb Mitomycin C Products Offered
12.4.5 Bristol-Myers Squibb Recent Development
12.5 Aspen
12.5.1 Aspen Corporation Information
12.5.2 Aspen Business Overview
12.5.3 Aspen Mitomycin C Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Aspen Mitomycin C Products Offered
12.5.5 Aspen Recent Development
12.6 Contura
12.6.1 Contura Corporation Information
12.6.2 Contura Business Overview
12.6.3 Contura Mitomycin C Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Contura Mitomycin C Products Offered
12.6.5 Contura Recent Development
12.7 Alkem Laboratories
12.7.1 Alkem Laboratories Corporation Information
12.7.2 Alkem Laboratories Business Overview
12.7.3 Alkem Laboratories Mitomycin C Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Alkem Laboratories Mitomycin C Products Offered
12.7.5 Alkem Laboratories Recent Development
12.8 Varifarma
12.8.1 Varifarma Corporation Information
12.8.2 Varifarma Business Overview
12.8.3 Varifarma Mitomycin C Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Varifarma Mitomycin C Products Offered
12.8.5 Varifarma Recent Development
12.9 APOGEPHA
12.9.1 APOGEPHA Corporation Information
12.9.2 APOGEPHA Business Overview
12.9.3 APOGEPHA Mitomycin C Sales, Revenue and Gross Margin (2016-2021)
12.9.4 APOGEPHA Mitomycin C Products Offered
12.9.5 APOGEPHA Recent Development
13 Mitomycin C Manufacturing Cost Analysis
13.1 Mitomycin C Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Mitomycin C
13.4 Mitomycin C Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Mitomycin C Distributors List
14.3 Mitomycin C Customers
15 Market Dynamics
15.1 Mitomycin C Market Trends
15.2 Mitomycin C Drivers
15.3 Mitomycin C Market Challenges
15.4 Mitomycin C Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Mitomycin C Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Mitomycin C Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Mitomycin C Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Mitomycin C Sales (K Units) by Region (2016-2021)
Table 5. Global Mitomycin C Sales Market Share by Region (2016-2021)
Table 6. Global Mitomycin C Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Mitomycin C Revenue Share by Region (2016-2021)
Table 8. Global Mitomycin C Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Mitomycin C Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Mitomycin C Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Mitomycin C Revenue Share Forecast by Region (2022-2027)
Table 12. Global Mitomycin C Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Mitomycin C Sales Share by Company (2016-2021)
Table 14. Global Mitomycin C Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Mitomycin C Revenue Share by Company (2016-2021)
Table 16. Global Mitomycin C by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mitomycin C as of 2020)
Table 17. Global Mitomycin C Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Mitomycin C Manufacturing Sites and Area Served
Table 19. Manufacturers Mitomycin C Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Mitomycin C Sales (K Units) by Type (2016-2021)
Table 22. Global Mitomycin C Sales Share by Type (2016-2021)
Table 23. Global Mitomycin C Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Mitomycin C Price (USD/Unit) by Type (2016-2021)
Table 25. Global Mitomycin C Sales Share by Type (2022-2027)
Table 26. Global Mitomycin C Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Mitomycin C Revenue Share by Type (2022-2027)
Table 28. Global Mitomycin C Price (USD/Unit) by Type (2022-2027)
Table 29. Global Mitomycin C Sales (K Units) by Application (2016-2021)
Table 30. Global Mitomycin C Sales Share by Application (2016-2021)
Table 31. Global Mitomycin C Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Mitomycin C Price (USD/Unit) by Application (2016-2021)
Table 33. Global Mitomycin C Sales (K Units) by Application (2022-2027)
Table 34. Global Mitomycin C Sales Share by Application (2022-2027)
Table 35. Global Mitomycin C Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Mitomycin C Revenue Share by Application (2022-2027)
Table 37. Global Mitomycin C Price (USD/Unit) by Application (2022-2027)
Table 38. North America Mitomycin C Sales (K Units) by Company (2016-2021)
Table 39. North America Mitomycin C Sales Market Share by Company (2016-2021)
Table 40. North America Mitomycin C Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Mitomycin C Revenue Market Share by Company (2016-2021)
Table 42. North America Mitomycin C Sales by Type (2016-2021) & (K Units)
Table 43. North America Mitomycin C Sales Market Share by Type (2016-2021)
Table 44. North America Mitomycin C Sales by Type (2022-2027) & (K Units)
Table 45. North America Mitomycin C Sales Market Share by Type (2022-2027)
Table 46. North America Mitomycin C Sales by Application (2016-2021) & (K Units)
Table 47. North America Mitomycin C Sales Market Share by Application (2016-2021)
Table 48. North America Mitomycin C Sales by Application (2022-2027) & (K Units)
Table 49. North America Mitomycin C Sales Market Share by Application (2022-2027)
Table 50. Europe Mitomycin C Sales (K Units) by Company (2016-2021)
Table 51. Europe Mitomycin C Sales Market Share by Company (2016-2021)
Table 52. Europe Mitomycin C Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Mitomycin C Revenue Market Share by Company (2016-2021)
Table 54. Europe Mitomycin C Sales by Type (2016-2021) & (K Units)
Table 55. Europe Mitomycin C Sales Market Share by Type (2016-2021)
Table 56. Europe Mitomycin C Sales by Type (2022-2027) & (K Units)
Table 57. Europe Mitomycin C Sales Market Share by Type (2022-2027)
Table 58. Europe Mitomycin C Sales by Application (2016-2021) & (K Units)
Table 59. Europe Mitomycin C Sales Market Share by Application (2016-2021)
Table 60. Europe Mitomycin C Sales by Application (2022-2027) & (K Units)
Table 61. Europe Mitomycin C Sales Market Share by Application (2022-2027)
Table 62. China Mitomycin C Sales (K Units) by Company (2016-2021)
Table 63. China Mitomycin C Sales Market Share by Company (2016-2021)
Table 64. China Mitomycin C Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Mitomycin C Revenue Market Share by Company (2016-2021)
Table 66. China Mitomycin C Sales by Type (2016-2021) & (K Units)
Table 67. China Mitomycin C Sales Market Share by Type (2016-2021)
Table 68. China Mitomycin C Sales by Type (2022-2027) & (K Units)
Table 69. China Mitomycin C Sales Market Share by Type (2022-2027)
Table 70. China Mitomycin C Sales by Application (2016-2021) & (K Units)
Table 71. China Mitomycin C Sales Market Share by Application (2016-2021)
Table 72. China Mitomycin C Sales by Application (2022-2027) & (K Units)
Table 73. China Mitomycin C Sales Market Share by Application (2022-2027)
Table 74. Japan Mitomycin C Sales (K Units) by Company (2016-2021)
Table 75. Japan Mitomycin C Sales Market Share by Company (2016-2021)
Table 76. Japan Mitomycin C Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Mitomycin C Revenue Market Share by Company (2016-2021)
Table 78. Japan Mitomycin C Sales by Type (2016-2021) & (K Units)
Table 79. Japan Mitomycin C Sales Market Share by Type (2016-2021)
Table 80. Japan Mitomycin C Sales by Type (2022-2027) & (K Units)
Table 81. Japan Mitomycin C Sales Market Share by Type (2022-2027)
Table 82. Japan Mitomycin C Sales by Application (2016-2021) & (K Units)
Table 83. Japan Mitomycin C Sales Market Share by Application (2016-2021)
Table 84. Japan Mitomycin C Sales by Application (2022-2027) & (K Units)
Table 85. Japan Mitomycin C Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Mitomycin C Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Mitomycin C Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Mitomycin C Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Mitomycin C Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Mitomycin C Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Mitomycin C Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Mitomycin C Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Mitomycin C Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Mitomycin C Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Mitomycin C Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Mitomycin C Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Mitomycin C Sales Market Share by Application (2022-2027)
Table 98. India Mitomycin C Sales (K Units) by Company (2016-2021)
Table 99. India Mitomycin C Sales Market Share by Company (2016-2021)
Table 100. India Mitomycin C Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Mitomycin C Revenue Market Share by Company (2016-2021)
Table 102. India Mitomycin C Sales by Type (2016-2021) & (K Units)
Table 103. India Mitomycin C Sales Market Share by Type (2016-2021)
Table 104. India Mitomycin C Sales by Type (2022-2027) & (K Units)
Table 105. India Mitomycin C Sales Market Share by Type (2022-2027)
Table 106. India Mitomycin C Sales by Application (2016-2021) & (K Units)
Table 107. India Mitomycin C Sales Market Share by Application (2016-2021)
Table 108. India Mitomycin C Sales by Application (2022-2027) & (K Units)
Table 109. India Mitomycin C Sales Market Share by Application (2022-2027)
Table 110. Kyowa-kirin Corporation Information
Table 111. Kyowa-kirin Description and Business Overview
Table 112. Kyowa-kirin Mitomycin C Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Kyowa-kirin Mitomycin C Product
Table 114. Kyowa-kirin Recent Development
Table 115. Intas Pharmaceuticals Corporation Information
Table 116. Intas Pharmaceuticals Description and Business Overview
Table 117. Intas Pharmaceuticals Mitomycin C Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Intas Pharmaceuticals Mitomycin C Product
Table 119. Intas Pharmaceuticals Recent Development
Table 120. Teva Corporation Information
Table 121. Teva Description and Business Overview
Table 122. Teva Mitomycin C Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Teva Mitomycin C Product
Table 124. Teva Recent Development
Table 125. Bristol-Myers Squibb Corporation Information
Table 126. Bristol-Myers Squibb Description and Business Overview
Table 127. Bristol-Myers Squibb Mitomycin C Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Bristol-Myers Squibb Mitomycin C Product
Table 129. Bristol-Myers Squibb Recent Development
Table 130. Aspen Corporation Information
Table 131. Aspen Description and Business Overview
Table 132. Aspen Mitomycin C Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Aspen Mitomycin C Product
Table 134. Aspen Recent Development
Table 135. Contura Corporation Information
Table 136. Contura Description and Business Overview
Table 137. Contura Mitomycin C Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Contura Mitomycin C Product
Table 139. Contura Recent Development
Table 140. Alkem Laboratories Corporation Information
Table 141. Alkem Laboratories Description and Business Overview
Table 142. Alkem Laboratories Mitomycin C Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Alkem Laboratories Mitomycin C Product
Table 144. Alkem Laboratories Recent Development
Table 145. Varifarma Corporation Information
Table 146. Varifarma Mitomycin C Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Varifarma Description and Business Overview
Table 148. Varifarma Mitomycin C Product
Table 149. Varifarma Recent Development
Table 150. APOGEPHA Corporation Information
Table 151. APOGEPHA Mitomycin C Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. APOGEPHA Description and Business Overview
Table 153. APOGEPHA Mitomycin C Product
Table 154. APOGEPHA Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Mitomycin C Distributors List
Table 158. Mitomycin C Customers List
Table 159. Mitomycin C Market Trends
Table 160. Mitomycin C Market Drivers
Table 161. Mitomycin C Market Challenges
Table 162. Mitomycin C Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Mitomycin C Product Picture
Figure 2. Global Mitomycin C Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Mitomycin C Sales Market Share by Application in 2021 & 2027
Figure 6. Cancer Treatment Examples
Figure 7. Ophthalmic Use Examples
Figure 8. Others Examples
Figure 9. Global Mitomycin C Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Mitomycin C Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Mitomycin C Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Mitomycin C Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Mitomycin C Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Mitomycin C Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Mitomycin C Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Mitomycin C Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Mitomycin C Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Mitomycin C Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Mitomycin C Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Mitomycin C Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Mitomycin C Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Mitomycin C Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Mitomycin C Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Mitomycin C Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Mitomycin C Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Mitomycin C Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Mitomycin C Players Market Share by Revenue in Mitomycin C: 2016 & 2020
Figure 28. Mitomycin C Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Mitomycin C Revenue Share by Type (2016-2021)
Figure 30. Global Mitomycin C Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Mitomycin C Revenue Share by Application (2016-2021)
Figure 32. Global Mitomycin C Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Mitomycin C Sales Market Share by Type in 2020
Figure 34. North America Mitomycin C Sales Market Share by Application in 2020
Figure 35. Europe Mitomycin C Sales Market Share by Type in 2020
Figure 36. Europe Mitomycin C Sales Market Share by Application in 2020
Figure 37. China Mitomycin C Sales Market Share by Type in 2020
Figure 38. China Mitomycin C Sales Market Share by Application in 2020
Figure 39. Japan Mitomycin C Sales Market Share by Type in 2020
Figure 40. Japan Mitomycin C Sales Market Share by Application in 2020
Figure 41. Southeast Asia Mitomycin C Sales Market Share by Type in 2020
Figure 42. Southeast Asia Mitomycin C Sales Market Share by Application in 2020
Figure 43. India Mitomycin C Sales Market Share by Type in 2020
Figure 44. India Mitomycin C Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Mitomycin C
Figure 47. Manufacturing Process Analysis of Mitomycin C
Figure 48. Mitomycin C Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
マイトマイシンのグローバル市場2021 Mitomycin is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase…- 世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年） Anaplastic thyroid cancer is one of four types ofthyroid cancer. It's very rare: The American ThyroidAssociation notes that this type represents less than 2 percent of all cases of thyroid cancer. Market Analysis and Insights: Global Anaplastic Thyroid Cancer Treatment Market The global Anaplastic T…
- 眼科用フェムト秒レーザーのグローバル市場2021 Femtosecond lasers are a subset of ultrafast lasers that emit optical pulses with a duration well below 1 ps, i.e., in the range of femtoseconds, widely used in the field of ophthalmology. Carl Zeiss Meditec was the global largest manufacturer in the Ophthalmic Femtosecond Lasers industry,with the p…
- 世界の転移性膵がん治療市場規模・現状・予測（2021年-2027年） Metastatic pancreatic cancer treatment, when cancer spreads outside of the pancreas, surgery may or may not be recommended. It’s more common for oncologists to recommend systemic treatments (which can circulate throughout the entire body and destroy cancerous cells in multiple locations) for metasta…
- 世界の去勢抵抗性前立腺がん治療市場規模・現状・予測（2021年-2027年） Prostate cancer that keeps growing even when the amount of testosterone in the body is reduced to very low levels. Many early-stage prostate cancers need normal levels of testosterone to grow, but castrate-resistant prostate cancers do not. Also called CRPC. Market Analysis and Insights: Global Cast…